US Stock MarketDetailed Quotes
ONCT Oncternal Therapeutics
- 0.5266
- 0.00000.00%
Close Dec 2 16:00 ET
1.56MMarket Cap-0.05P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.5266Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.96MShares12.398052wk High0.17P/B1.43MFloat Cap0.526652wk Low--Dividend TTM2.71MShs Float3583.9949Historical High--Div YieldTTM0.00%Amplitude0.5260Historical Low--Avg Price1Lot Size
Oncternal Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -26.12%-6.95M | 37.15%-5.82M | 32.19%-7.44M | 12.37%-32.16M | 28.69%-6.42M | 53.93%-5.51M | -29.92%-9.26M | -27.46%-10.97M | -38.04%-36.7M | -36.06%-9M |
| Net income from continuing operations | 14.18%-8.46M | 4.54%-8.56M | 26.98%-8.39M | 10.62%-39.48M | 19.61%-9.16M | 11.35%-9.86M | 23.64%-8.97M | -15.98%-11.49M | -40.97%-44.17M | -41.21%-11.4M |
| Other non cash items | -52.00%36K | -5.41%35K | -10.81%33K | -2.79%174K | -28.57%25K | 114.29%75K | -43.08%37K | -15.91%37K | 5.92%179K | -20.45%35K |
| Change In working capital | -109.64%-281K | 199.48%1.54M | 85.98%-135K | 1,946.38%1.27M | 36.64%869K | 202.28%2.92M | -153.92%-1.55M | -33.01%-963K | 94.69%-69K | 312.00%636K |
| -Change in prepaid assets | -40.52%1.37M | 64.51%-351K | -64.65%327K | 225.25%2.62M | -33.97%383K | 178.11%2.31M | -219.30%-989K | 267.27%925K | -193.83%-2.1M | 1,015.38%580K |
| -Change in payables and accrued expense | -621.27%-1.64M | 352.53%1.9M | 77.42%-487K | -216.55%-2.57M | -88.52%24K | 37.55%315K | -139.70%-752K | -1,598.43%-2.16M | 81.48%2.21M | 239.33%209K |
| -Change in other current liabilities | -83.33%-44K | -16.22%-43K | -8.11%-40K | 36.31%-114K | 54.29%-16K | 31.43%-24K | 43.08%-37K | 15.91%-37K | -5.92%-179K | 20.45%-35K |
| -Change in other working capital | -89.34%34K | -85.28%34K | -78.76%65K | --1.33M | --478K | 443.01%319K | --231K | --306K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -26.12%-6.95M | 37.15%-5.82M | 32.19%-7.44M | 12.37%-32.16M | 28.69%-6.42M | 53.93%-5.51M | -29.92%-9.26M | -27.46%-10.97M | -38.04%-36.7M | -36.06%-9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 193.23%13.65M | -58.07%5.81M | 145.01%7.22M | 102.46%651K | 93.18%-1.81M | 4.66M | 13.85M | -16.05M | -26.5M | -26.5M |
| Net investment purchase and sale | 193.23%13.65M | -58.07%5.81M | 145.01%7.22M | 102.46%651K | 93.18%-1.81M | --4.66M | --13.85M | ---16.05M | ---26.5M | ---26.5M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 193.23%13.65M | -58.07%5.81M | 145.01%7.22M | 102.46%651K | 93.18%-1.81M | --4.66M | --13.85M | ---16.05M | ---26.5M | ---26.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -107.77%-87K | -88.85%1.07M | -100.05%-1K | -101.33%-49K | -100.03%-1K | 1.12M | 1,452.51%9.58M | 201,300.00%2.01M |
| Net common stock issuance | --0 | --0 | -107.77%-87K | -88.85%1.07M | -100.05%-1K | -101.33%-49K | -100.03%-1K | --1.12M | --9.58M | --2.01M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | -107.77%-87K | -88.85%1.07M | -100.05%-1K | -101.33%-49K | -100.03%-1K | --1.12M | 1,452.51%9.58M | 201,300.00%2.01M |
| Net cash flow | ||||||||||
| Beginning cash position | -59.69%6.38M | -43.12%6.4M | -81.97%6.7M | -59.08%37.14M | -78.87%14.93M | -79.93%15.83M | -86.31%11.24M | -59.08%37.14M | -22.25%90.77M | -27.47%70.63M |
| Current changes in cash | 838.37%6.7M | -100.31%-14K | 98.84%-301K | 43.22%-30.45M | 75.43%-8.23M | 89.04%-907K | 240.78%4.59M | -200.93%-25.9M | -106.46%-53.62M | -406.21%-33.49M |
| End cash Position | -12.37%13.08M | -59.69%6.38M | -43.12%6.4M | -81.97%6.7M | -81.97%6.7M | -78.87%14.93M | -79.93%15.83M | -86.31%11.24M | -59.08%37.14M | -59.08%37.14M |
| Free cash flow | -26.12%-6.95M | 37.15%-5.82M | 32.19%-7.44M | 12.37%-32.16M | 28.69%-6.42M | 53.93%-5.51M | -29.92%-9.26M | -27.46%-10.97M | -38.04%-36.7M | -36.06%-9M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data